Evidence mapPaperPMID 40978378Full record

ReviewACS omega2025

Recent Advances in Electrically Stimulated Insulin Delivery Systems.

Carlos Alemán, Helena Muñoz-Galán, Maria M Pérez-Madrigal

Abstract readReview
In one paragraph

Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carlos AlemánDepartament d'Enginyeria Química, Campus Diagonal Besòs (EEBE), Universitat Politècnica de Catalunya, Av. Eduard Maristany 10-14, 08019 Barcelona, Spain.ORCID https://orcid.org/0000-0003-4462-6075
Helena Muñoz-GalánDepartament d'Enginyeria Química, Campus Diagonal Besòs (EEBE), Universitat Politècnica de Catalunya, Av. Eduard Maristany 10-14, 08019 Barcelona, Spain.
Maria M Pérez-MadrigalDepartament d'Enginyeria Química, Campus Diagonal Besòs (EEBE), Universitat Politècnica de Catalunya, Av. Eduard Maristany 10-14, 08019 Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus has become one of the greatest medical challenges affecting millions of people globally. Non- and minimally invasive approaches for insulin release are currently being intensively investigated to improve the treatment efficacy and quality of life for diabetic patients. Electrically triggered drug release exhibits tremendous potential since it allows medications to be dosed intermittently on demand and over a long period of time using simple, safe, and inexpensive approaches. Despite such advantages, the use of electrical signals has been mainly focused on the delivery of small drugs, with the administration of protein-based drugs, such as insulin, being addressed only sporadically. However, in recent years, the controlled release of insulin through electrical stimulation has begun to be seriously studied, attracting interest because of its capacity to reduce the incidence of hyperglycemia, which further reduces the potential complications in diabetic patients. This review examines the state of the art of electroregulated insulin delivery systems, discussing the current different approaches existing and analyzing the advantages and disadvantages of each one of them.

Identifiers

PMID40978378
PMCPMC12444518

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.